310 related articles for article (PubMed ID: 12821359)
21. Endometrial stromal sarcoma of twenty cases.
Huang KT; Chen CA; Tseng GC; Chen TM; Cheng WF; Hsieh CY
Acta Obstet Gynecol Scand; 1996 Jul; 75(6):551-5. PubMed ID: 8693932
[TBL] [Abstract][Full Text] [Related]
22. Low-grade endometrial stromal sarcoma presenting as vaginal nodule.
Corpa MV; Serafini EP; Bacchi CE
Ann Diagn Pathol; 2004 Oct; 8(5):295-8. PubMed ID: 15494937
[TBL] [Abstract][Full Text] [Related]
23. Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.
Park JY; Baek MH; Park Y; Kim YT; Nam JH
Virchows Arch; 2018 Jul; 473(1):61-69. PubMed ID: 29869299
[TBL] [Abstract][Full Text] [Related]
24. Endometrial stromal sarcoma: objective response to letrozole.
Maluf FC; Sabbatini P; Schwartz L; Xia J; Aghajanian C
Gynecol Oncol; 2001 Aug; 82(2):384-8. PubMed ID: 11531300
[TBL] [Abstract][Full Text] [Related]
25. Hormonal therapy of endometrial stromal sarcoma.
Reich O; Regauer S
Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
[TBL] [Abstract][Full Text] [Related]
26. Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.
Kurihara S; Oda Y; Ohishi Y; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
Mod Pathol; 2010 Feb; 23(2):225-34. PubMed ID: 19898427
[TBL] [Abstract][Full Text] [Related]
27. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
Barakat RR; Bundy BN; Spirtos NM; Bell J; Mannel RS;
J Clin Oncol; 2006 Feb; 24(4):587-92. PubMed ID: 16446331
[TBL] [Abstract][Full Text] [Related]
28. Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy.
Cheng X; Yang G; Schmeler KM; Coleman RL; Tu X; Liu J; Kavanagh JJ
Gynecol Oncol; 2011 May; 121(2):323-7. PubMed ID: 21277011
[TBL] [Abstract][Full Text] [Related]
29. Endometrial Stromal Sarcoma Arising from Endometrial Polyp: A Case Report.
Sato S; Ojima Y; Kanda M; Kizaki T; Ohara N
Kobe J Med Sci; 2018 Sep; 64(2):E36-E42. PubMed ID: 30381725
[TBL] [Abstract][Full Text] [Related]
30. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer.
Singer CF; Kronsteiner N; Marton E; Walter I; Kubista M; Czerwenka K; Schreiber M; Tschugguel W; Wieser F; Kubista E
Gynecol Oncol; 2002 Jun; 85(3):423-30. PubMed ID: 12051868
[TBL] [Abstract][Full Text] [Related]
32. Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases.
Kurihara S; Oda Y; Ohishi Y; Iwasa A; Takahira T; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1228-38. PubMed ID: 18580489
[TBL] [Abstract][Full Text] [Related]
33. Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study.
Sabini G; Chumas JC; Mann WJ
Am J Clin Pathol; 1992 Mar; 97(3):381-6. PubMed ID: 1371902
[TBL] [Abstract][Full Text] [Related]
34. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
35. Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.
Saegusa M; Okayasu I
Jpn J Cancer Res; 2000 May; 91(5):510-8. PubMed ID: 10835496
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma.
Deshmukh U; Black J; Perez-Irizarry J; Passarelli R; Levy K; Rostkowski A; Hui P; Rutherford TJ; Santin AD; Azodi M; Silasi DA; Ratner E; Litkouhi B; Schwartz PE
Reprod Sci; 2019 May; 26(5):600-608. PubMed ID: 29843577
[TBL] [Abstract][Full Text] [Related]
37. MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus.
Popiolek D; Yee H; Levine P; Vamvakas E; Demopoulos RI
Gynecol Oncol; 2003 Aug; 90(2):353-7. PubMed ID: 12893199
[TBL] [Abstract][Full Text] [Related]
38. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
Liao QP; Wu C; Zheng H; Yu L
Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
[TBL] [Abstract][Full Text] [Related]
39. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment.
Beck TL; Singhal PK; Ehrenberg HM; Rose PG; Lele SB; Krivak TC; McBee WC
Gynecol Oncol; 2012 Apr; 125(1):141-4. PubMed ID: 22119993
[TBL] [Abstract][Full Text] [Related]
40. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.
van der Putten LJM; Visser NCM; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Werner HMJ; Amant F; Massuger LFAG; Pijnenborg JMA
Int J Gynecol Cancer; 2018 Mar; 28(3):514-523. PubMed ID: 29324536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
